Literature DB >> 19960259

Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.

Hongwei Zhang1, Mengbin Li, Yu Han, Liu Hong, Taiqian Gong, Li Sun, Xiushan Zheng.   

Abstract

BACKGROUND: So far, the miRNAs involved in multidrug resistance of esophageal cancer have not been reported. AIMS AND METHODS: Here we have firstly investigated the roles of miR-27a in multidrug resistance of esophageal squamous cell carcinoma using MTT assay, flow cytometry assay, and reporter gene assay, etc.
RESULTS: Down-regulation of miR-27a could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-non-related drugs on esophageal cancer cells, and might promote ADR-induced apoptosis, accompanied by increased accumulation and decreased releasing amount of ADR. Down-regulation of miR-27a could significantly decrease the expression of P-glycoprotein, Bcl-2, and the transcription of the multidrug resistance gene 1, but up-regulate the expression of Bax.
CONCLUSIONS: MiR-27a might play important roles in multidrug resistance of esophageal cancer. The further study of the biological functions of miR-27a might be helpful for developing possible strategies to treat esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960259     DOI: 10.1007/s10620-009-1051-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

Review 1.  Concise review: MicroRNA expression in multipotent mesenchymal stromal cells.

Authors:  Uma Lakshmipathy; Ronald P Hart
Journal:  Stem Cells       Date:  2007-11-08       Impact factor: 6.277

2.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

3.  ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.

Authors:  Liu Hong; Taidong Qiao; Yu Han; Shuang Han; Xiaoyin Zhang; Tao Lin; Juan Gao; Pengtao Zhao; Zhen Chen; Daiming Fan
Journal:  Biochem Cell Biol       Date:  2006-04       Impact factor: 3.626

Review 4.  Chemotherapeutic agents that induce mitochondrial apoptosis.

Authors:  Tadashi Asakura; Kiyoshi Ohkawa
Journal:  Curr Cancer Drug Targets       Date:  2004-11       Impact factor: 3.428

5.  Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32.

Authors:  Liu Hong; Jin Wang; Ying Han; Yunping Zhao; Juan Gao; Jun Wang; Yu Han; Xiaoyin Zhang; Li Yan; Xinmin Zhou; Taidong Qiao; Zhen Chen; Daiming Fan
Journal:  Cell Biol Int       Date:  2007-03-21       Impact factor: 3.612

6.  MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.

Authors:  Wei-Chih Tsai; Paul Wei-Che Hsu; Tsung-Ching Lai; Gar-Yang Chau; Ching-Wen Lin; Chun-Ming Chen; Chien-Der Lin; Yu-Lun Liao; Jui-Ling Wang; Yat-Pang Chau; Ming-Ta Hsu; Michael Hsiao; Hsien-Da Huang; Ann-Ping Tsou
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.

Authors:  Tao Liu; Hua Tang; Yuanyuan Lang; Min Liu; Xin Li
Journal:  Cancer Lett       Date:  2008-09-13       Impact factor: 8.679

8.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

9.  L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

Authors:  Mina Fogel; Paul Gutwein; Sabine Mechtersheimer; Svenja Riedle; Alexander Stoeck; Asya Smirnov; Lutz Edler; Alon Ben-Arie; Monica Huszar; Peter Altevogt
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

10.  A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Tomoyuki Shibata; Mitsuo Nagasaka; Masakatsu Nakamura; Yoshio Kamiya; Hiroshi Fujita; Shin Hasegawa; Tamaki Takagi; Fang-Yu Wang; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-03-16       Impact factor: 3.487

View more
  49 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

Authors:  Yi Zhou; Liu Hong
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-13

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  MicroRNAs and esophageal cancer.

Authors:  Santosh Kumar Patnaik; Reema Mallick; Sai Yendamuri
Journal:  J Gastrointest Oncol       Date:  2010-09

Review 5.  MicroRNAs and their relevance to ABC transporters.

Authors:  Sierk Haenisch; Anneke Nina Werk; Ingolf Cascorbi
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

6.  ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction.

Authors:  Xing Chen; Zhihan Zhou; Yan Zhao
Journal:  RNA Biol       Date:  2018-05-25       Impact factor: 4.652

7.  Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.

Authors:  Ying-Ying Jin; Qing-Juan Chen; Kun Xu; Hong-Tao Ren; Xing Bao; Yi-Nan Ma; Yang Wei; Hong Bing Ma
Journal:  Mol Cell Biochem       Date:  2016-09-19       Impact factor: 3.396

Review 8.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

Authors:  J Huang; S-Y Zhang; Y-M Gao; Y-F Liu; Y-B Liu; Z-G Zhao; K Yang
Journal:  Cell Prolif       Date:  2014-06-06       Impact factor: 6.831

9.  Deep sequencing identifies deregulation of microRNAs involved with vincristine drug-resistance of colon cancer cells.

Authors:  Wei-Hua Dong; Qin Li; Xiao-Yan Zhang; Qing Guo; Huizheng Li; Tian-Yun Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.

Authors:  Ravindresh Chhabra; Richa Dubey; Neeru Saini
Journal:  Mol Cancer       Date:  2010-09-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.